Iliac crest bone marrow aspiration remains the gold standard for sampling bone marrow, performed over 500,000 times annually in the United States alone. The procedure involves inserting a specialized needle into the iliac crest — the large, curved bone forming the top of your pelvis — to withdraw liquid marrow for diagnostic analysis. It’s the single most informative test in hematology, capable of diagnosing leukemias, lymphomas, myelodysplastic syndromes, and dozens of other conditions that blood tests alone can’t pin down.
Whether you’re a medical student preparing for your first aspiration, a clinician refining your technique, or a patient trying to understand what’s ahead, this guide covers the practical techniques, established clinical applications, and the recent advances reshaping how we perform and interpret this procedure.
Why the Iliac Crest? Anatomy and Site Selection
The posterior superior iliac spine (PSIS) is the preferred aspiration site in adults for good reason. The bone here is thick enough to anchor a needle securely, the marrow cavity is large and consistently cellular, and — critically — there are no major vessels or organs directly beneath the puncture site. The risk of serious complications at the PSIS is roughly 0.05–0.07%, making it one of the safest biopsy sites in medicine.
The anterior superior iliac spine (ASIS) serves as an alternative when patients can’t lie prone — for example, morbidly obese patients or those on mechanical ventilation. In children under 12 months, the tibial tuberosity is sometimes used, and the sternum remains an option for aspiration-only procedures in adults, though it carries a small but real risk of cardiac puncture.
| Aspiration Site | Typical Patient | Advantages | Key Risk |
|---|---|---|---|
| Posterior superior iliac spine (PSIS) | Adults (standard) | Highest marrow yield, safest anatomy | Minimal — local hematoma |
| Anterior superior iliac spine (ASIS) | Obese or ventilated patients | Accessible in supine position | Slightly higher pain scores |
| Sternum | Adults (aspiration only) | Thin cortex, easy access | Rare but fatal cardiac tamponade |
| Tibia | Infants < 12 months | Large marrow space relative to body size | Growth plate injury if misplaced |
Step-by-Step Aspiration Technique
Pre-Procedure Preparation
- Coagulation check: Platelet count > 20,000/µL is generally considered safe; INR should be < 1.5. Severely thrombocytopenic patients may need platelet transfusion beforehand.
- Informed consent: Explain expected pain (a deep pressure/pulling sensation lasting 10–30 seconds during aspiration), complication rates, and alternatives.
- Positioning: Prone or lateral decubitus for PSIS; supine for ASIS. Locate the landmark by palpating the bony prominence at the belt line posteriorly.
The Procedure Itself
- Skin prep and anesthesia: Chlorhexidine or betadine scrub. Infiltrate 1–2% lidocaine (typically 10–20 mL) into the skin, subcutaneous tissue, and — most importantly — the periosteum. Inadequate periosteal anesthesia is the number one cause of procedure-related pain.
- Needle insertion: A Jamshidi or Illinois needle (11–13 gauge) is advanced through the cortical bone with a twisting motion until a “give” is felt as you enter the marrow cavity, typically at 1–3 cm depth.
- Aspiration: Remove the stylet, attach a 10–20 mL syringe, and aspirate sharply. Pull only 0.5–2 mL initially — larger volumes dilute the sample with peripheral blood (hemodilution), degrading diagnostic quality.
- Biopsy (if needed): Advance the needle further or use a separate biopsy needle to obtain a core of at least 1.5–2 cm in length. Shorter cores are associated with inadequate assessment, particularly for staging lymphomas.
- Post-aspiration: Apply firm pressure for 5–10 minutes. A pressure dressing stays on for 24–48 hours.
Reducing Patient Pain: What the Evidence Says
A 2020 randomized controlled trial in British Journal of Haematology demonstrated that powered bone marrow biopsy devices (like the OnControl system) reduced procedure time by 40% and significantly lowered pain scores compared to manual needles (VAS 3.2 vs. 5.1, p < 0.001). Conscious sedation with midazolam and fentanyl further reduces discomfort, though many centers still perform the procedure with local anesthesia alone.
Other evidence-based strategies include nitrous oxide (Entonox), which showed a 30% reduction in pain scores in a multicenter trial, and the “J-technique” — redirecting the needle at a slight angle after initial cortical penetration to reduce periosteal stimulation.
Clinical Applications: When Is Bone Marrow Aspiration Indicated?
The indications span virtually all of hematology and parts of oncology, infectious disease, and rheumatology:
- Unexplained cytopenias: Persistent anemia, leukopenia, or thrombocytopenia without a clear peripheral cause
- Suspected hematologic malignancy: Circulating blasts, abnormal lymphocytes, or clinical suspicion of leukemia/lymphoma
- Staging and response assessment: Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, neuroblastoma
- Fever of unknown origin: Particularly when granulomatous disease, leishmaniasis, or disseminated fungal infections are suspected
- Iron stores evaluation: Prussian blue staining of marrow remains the gold standard for diagnosing iron deficiency when ferritin is unreliable (e.g., concurrent inflammation)
- Pre-transplant assessment: Evaluating donor marrow cellularity and ruling out occult disease
Recent Advances Changing the Field
Next-Generation Sequencing (NGS) on Aspirate Samples
Modern aspirates aren’t just smeared on slides anymore. Targeted NGS panels covering 50–500+ genes can now be run directly on aspirate material, identifying actionable mutations in AML (FLT3, NPM1, IDH1/2), MDS (SF3B1, TP53), and MPN (JAK2, CALR) within 5–7 business days. This has fundamentally changed how we risk-stratify patients and select targeted therapies.
AI-Assisted Morphology
Machine learning algorithms now achieve >90% concordance with expert hematopathologists in classifying marrow cell types. Companies like Scopio Labs and Cellavision are deploying digital morphology platforms that scan entire aspirate smears and flag abnormal cells, reducing turnaround time and inter-observer variability.
Minimal Residual Disease (MRD) Testing
Multiparameter flow cytometry (detecting 1 abnormal cell in 10,000) and real-time quantitative PCR (sensitivity down to 1 in 1,000,000) performed on aspirate samples now guide decisions about transplant timing, therapy de-escalation, and relapse prediction in acute leukemias and multiple myeloma.
Ultrasound-Guided Aspiration
Point-of-care ultrasound for landmark confirmation is gaining traction, particularly in obese patients where the PSIS may be difficult to palpate. Early data suggest it reduces the number of needle passes and may lower dry tap rates.
Complications: What Can Go Wrong?
Serious complications are rare but real. A large British registry study of over 54,000 procedures reported an adverse event rate of 0.05% and a mortality rate of approximately 0.0003% (roughly 1 in 300,000).
- Pain beyond expected: Most common “complication” — affects 20–30% of patients for 24–48 hours post-procedure
- Hemorrhage: Usually self-limited hematoma; severe retroperitoneal bleeding is exceedingly rare but reported in patients on anticoagulants or with severe thrombocytopenia
- Infection: < 0.01% incidence; slightly higher in immunocompromised patients
- Needle breakage: Rare with modern needles; more common with manual techniques in patients with very dense (osteosclerotic) bone
- Dry tap: No marrow obtained — occurs in 2–7% of cases, often due to myelofibrosis, packed marrow (leukemia), or technical issues. A core biopsy should always be obtained when a dry tap occurs.
Frequently Asked Questions
How painful is a bone marrow aspiration from the iliac crest?
Most patients rate the aspiration moment itself as a 4–6 out of 10 on a pain scale — a sharp, deep pulling sensation that lasts about 10–30 seconds. The rest of the procedure, when properly anesthetized, is pressure rather than pain. Post-procedure soreness typically resolves within 48 hours. Powered devices and conscious sedation can significantly reduce discomfort.
How long does the procedure take?
From positioning to bandage, expect 15–30 minutes total. The actual aspiration takes under a minute. If a trephine biopsy is also performed, add another 5–10 minutes. Recovery and observation typically last 30–60 minutes afterward.
What’s the difference between aspiration and biopsy?
An aspiration withdraws liquid marrow for cytology, flow cytometry, cytogenetics, and molecular testing. A trephine biopsy removes a solid core of bone and marrow for histologic architecture — cellularity, fibrosis, and tumor infiltration patterns that liquid samples can’t capture. They’re complementary, and most guidelines recommend performing both simultaneously.
Can you eat or drink before the procedure?
If performed under local anesthesia only, there are no fasting requirements. If conscious sedation is planned, most institutions require 6 hours of fasting for solids and 2 hours for clear liquids.
When will results be available?
Preliminary morphology results (the smear review) are often available within 24–48 hours. Flow cytometry takes 1–3 days. Cytogenetics require 7–14 days for karyotyping, and molecular/NGS results may take 7–21 days depending on the panel and laboratory.
Key Takeaways
- The posterior superior iliac spine remains the safest and most reliable site for bone marrow aspiration in adults, with a serious complication rate under 0.1%.
- Adequate periosteal anesthesia is the single most important factor in reducing procedural pain — don’t rush it.
- Limit initial aspiration volume to 0.5–2 mL to avoid hemodilution and preserve diagnostic quality.
- NGS panels, AI-assisted morphology, and MRD testing are transforming what we can learn from a single aspirate sample.
- Always perform a core biopsy alongside aspiration — especially when a dry tap occurs or when evaluating for fibrosis, lymphoma staging, or marrow cellularity.
